Search - tctmd.com

Displaying 41 - 60 of 116

Sort: Relevancy | Date

News Daily News

Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials

Todd Neale

February 06, 2018

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

Presentation TCT 2017

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Jacek Legutko

November 01, 2017

Presentation TCT 2017

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Evald H. Christiansen

November 01, 2017

Presentation TCT 2017

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Presenter: James B. Hermiller Jr., John D. Puskas, Bernard J. Gersh

November 01, 2017

Presentation TCT 2017

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, John D. Puskas

October 31, 2017

Presentation TCT 2017

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

Presenter: Evald H. Christiansen, Erick Schampaert, Marco V. Wainstein

October 31, 2017

Presentation TCT 2017

The Role of Left Main PCI After EXCEL and NOBLE

Presenter: Alaide Chieffo, Jonathan M. Hill, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Should Recommendations for Left Main PCI Be Revised? Personal Perspectives and the Guidelines Process

Presenter: Antonio Colombo, David E. Kandzari, Stephan Windecker

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE III: Fu-Wai Left Main Registry

Presenter: Antonio Colombo, David E. Kandzari, Bo Xu

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Presenter: Antonio Colombo, David E. Kandzari, Duk-Woo Park

October 31, 2017

Presentation TCT 2017

Exploring Diversity and Generalizability of EXCEL/NOBLE I: DELTA-2

Presenter: Antonio Colombo, David E. Kandzari, Alaide Chieffo

October 31, 2017

Presentation TCT 2017

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

Presenter: Antonio Colombo, David E. Kandzari, Marie-Claude Morice

October 31, 2017

Presentation TCT 2017

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Presenter: Antonio Colombo, David E. Kandzari, John D. Puskas

October 31, 2017

Presentation TCT 2017

Insights From New Meta-Analyses of PCI vs CABG for Left Main Revascularization

Presenter: Antonio Colombo, David E. Kandzari, Davide Capodanno

October 31, 2017

Presentation TCT 2017

NOBLE: Core Findings Revisited and New Data

Presenter: Antonio Colombo, David E. Kandzari, Evald H. Christiansen

October 31, 2017

EXCEL: Core Findings Revisited and New Data

Presentation TCT 2017

EXCEL Trial 3-Year Results Updated and New Data

Presenter: Antonio Colombo, David E. Kandzari, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Daily News

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

Todd Neale

July 20, 2017

News Opinion Fellow Talk

The Left Main Debate: What Does it Mean for the Future of Intervention?

Tiffany Patterson, MBBS

April 12, 2017

Advertisement

Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Heart Team Evidence: Synthesizing the PCI vs CABG Left Main Data From EXCEL, NOBLE, and SYNTAX

Debate: EXCEL and NOBLE Prove That PCI Is Still Far From Being an Acceptable Alternative to CABG for Left Main Revascularization, With the Exception of a Small Proportion of Patients!

Debate: Based on EXCEL and NOBLE, PCI Should Become Class IA for Left Main Revascularization If Technically Feasible, at Least in Intermediate and Low SYNTAX Score Patients!

The Role of Left Main PCI After EXCEL and NOBLE

Should Recommendations for Left Main PCI Be Revised? Personal Perspectives and the Guidelines Process

Exploring Diversity and Generalizability of EXCEL/NOBLE III: Fu-Wai Left Main Registry

Exploring Diversity and Generalizability of EXCEL/NOBLE II: IRIS-MAIN

Exploring Diversity and Generalizability of EXCEL/NOBLE I: DELTA-2

Insights From the PCI Arms in EXCEL and NOBLE: Can the Outcomes Be Further Improved?

Insights From the CABG Arms in EXCEL and NOBLE: What Met Expectations, What Didnt?

Insights From New Meta-Analyses of PCI vs CABG for Left Main Revascularization

NOBLE: Core Findings Revisited and New Data

EXCEL Trial 3-Year Results Updated and New Data

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Predictors of Bad Outcomes After Unprotected Left Main Disease Similar Regardless of Treatment

The Left Main Debate: What Does it Mean for the Future of Intervention?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content